Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Eye Drops for Corneal Surface Diseases
NCT05320172Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 3, open-label, single-arm trial of platelet-rich plasma autologous eye drops in persistent corneal epithelial defect (PED) and dry eye disease (DED), sponsored by Assiut University. Primary endpoints: Change in size of corneal epithelial defect at 1 month, Change in visual acuity at 1 month and 1 more. Status: unknown.
02
Drugs
platelet-rich plasma autologous eye drops
03
Conditions
persistent corneal epithelial defect (PED)dry eye disease (DED)
Beyond the preview
Go deeper on NCT05320172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320172.